51 related articles for article (PubMed ID: 22593485)
21. [Relationship between raf kinase inhibitor protein and metastasis of ovarian carcinoma].
Wang Y; Yang J; Gao Y; Zhao XL; Li HZ; Yao Z
Zhonghua Fu Chan Ke Za Zhi; 2009 Jul; 44(7):522-8. PubMed ID: 19957553
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of BAD phosphorylation either at serine 112 via extracellular signal-regulated protein kinase cascade or at serine 136 via Akt cascade sensitizes human ovarian cancer cells to cisplatin.
Hayakawa J; Ohmichi M; Kurachi H; Kanda Y; Hisamoto K; Nishio Y; Adachi K; Tasaka K; Kanzaki T; Murata Y
Cancer Res; 2000 Nov; 60(21):5988-94. PubMed ID: 11085518
[TBL] [Abstract][Full Text] [Related]
23. Cafestol, a coffee-specific diterpene, induces apoptosis in renal carcinoma Caki cells through down-regulation of anti-apoptotic proteins and Akt phosphorylation.
Choi MJ; Park EJ; Oh JH; Min KJ; Yang ES; Kim YH; Lee TJ; Kim SH; Choi YH; Park JW; Kwon TK
Chem Biol Interact; 2011 Apr; 190(2-3):102-8. PubMed ID: 21334318
[TBL] [Abstract][Full Text] [Related]
24. Growth inhibitory effect of D-allose on human ovarian carcinoma cells in vitro.
Sui L; Dong Y; Watanabe Y; Yamaguchi F; Hatano N; Izumori K; Tokuda M
Anticancer Res; 2005; 25(4):2639-44. PubMed ID: 16080505
[TBL] [Abstract][Full Text] [Related]
25. Novel phosphoinositide 3-kinase/mTOR dual inhibitor, NVP-BGT226, displays potent growth-inhibitory activity against human head and neck cancer cells in vitro and in vivo.
Chang KY; Tsai SY; Wu CM; Yen CJ; Chuang BF; Chang JY
Clin Cancer Res; 2011 Nov; 17(22):7116-26. PubMed ID: 21976531
[TBL] [Abstract][Full Text] [Related]
26. The antiproliferative effect of Quercetin in cancer cells is mediated via inhibition of the PI3K-Akt/PKB pathway.
Gulati N; Laudet B; Zohrabian VM; Murali R; Jhanwar-Uniyal M
Anticancer Res; 2006; 26(2A):1177-81. PubMed ID: 16619521
[TBL] [Abstract][Full Text] [Related]
27. Anti-tumour activity of phosphoinositide-3-kinase antagonist AEZS 126 in models of triple-negative breast cancer.
Hahne JC; Schmidt H; Meyer SR; Engel JB; Dietl J; Honig A
J Cancer Res Clin Oncol; 2013 Jun; 139(6):905-14. PubMed ID: 23440492
[TBL] [Abstract][Full Text] [Related]
28. Ascorbyl stearate inhibits cell proliferation and tumor growth in human ovarian carcinoma cells by targeting the PI3K/AKT pathway.
Fang Q; Naidu KA; Naidu KA; Zhao H; Sun M; Dan HC; Nasir A; Kaiser HE; Cheng JQ; Nicosia SV; Coppola D
Anticancer Res; 2006; 26(1A):203-9. PubMed ID: 16475700
[TBL] [Abstract][Full Text] [Related]
29. Anti-tumour activity of phosphoinositide-3-kinase antagonist AEZS-126 in models of ovarian cancer.
Hahne JC; Kurz A; Meyer SR; Dietl J; Engel JB; Honig A
Arch Gynecol Obstet; 2015 Jan; 291(1):131-41. PubMed ID: 25115278
[TBL] [Abstract][Full Text] [Related]
30. VDX-111, a novel small molecule, induces necroptosis to inhibit ovarian cancer progression.
Persenaire C; Babbs B; Yamamoto TM; Nebbia M; Jordan KR; Adams S; Lambert JR; Bitler BG
Mol Carcinog; 2024 Jul; 63(7):1248-1259. PubMed ID: 38558423
[TBL] [Abstract][Full Text] [Related]
31. Isothiocyanate NB7M causes selective cytotoxicity, pro-apoptotic signalling and cell-cycle regression in ovarian cancer cells.
Singh RK; Lange TS; Kim KK; Singh AP; Vorsa N; Brard L
Br J Cancer; 2008 Dec; 99(11):1823-31. PubMed ID: 19002174
[TBL] [Abstract][Full Text] [Related]
32. Alternative to the soft-agar assay that permits high-throughput drug and genetic screens for cellular transformation.
Rotem A; Janzer A; Izar B; Ji Z; Doench JG; Garraway LA; Struhl K
Proc Natl Acad Sci U S A; 2015 May; 112(18):5708-13. PubMed ID: 25902495
[TBL] [Abstract][Full Text] [Related]
33. A novel intracellular peptide derived from g1/s cyclin d2 induces cell death.
de Araujo CB; Russo LC; Castro LM; Forti FL; do Monte ER; Rioli V; Gozzo FC; Colquhoun A; Ferro ES
J Biol Chem; 2014 Jun; 289(24):16711-26. PubMed ID: 24764300
[TBL] [Abstract][Full Text] [Related]
34. HSF1 Pathway Inhibitor Clinical Candidate (CCT361814/NXP800) Developed from a Phenotypic Screen as a Potential Treatment for Refractory Ovarian Cancer and Other Malignancies.
Pasqua AE; Sharp SY; Chessum NEA; Hayes A; Pellegrino L; Tucker MJ; Miah A; Wilding B; Evans LE; Rye CS; Mok NY; Liu M; Henley AT; Gowan S; De Billy E; Te Poele R; Powers M; Eccles SA; Clarke PA; Raynaud FI; Workman P; Jones K; Cheeseman MD
J Med Chem; 2023 Apr; 66(8):5907-5936. PubMed ID: 37017629
[TBL] [Abstract][Full Text] [Related]
35. Erratum to: Inhibition of ovarian cancer cell growth by a novel TAK1 inhibitor LYTAK1.
Wei L; Ying L; Chunxia Y
Cancer Chemother Pharmacol; 2015 Nov; 76(5):1099. PubMed ID: 26449223
[No Abstract] [Full Text] [Related]
36. How to win the ovarian cancer stem cell battle: destroying the roots.
Takahashi A; Hong L; Chefetz I
Cancer Drug Resist; 2020; 3(4):1021-1033. PubMed ID: 35582216
[TBL] [Abstract][Full Text] [Related]
37. Mechanisms of Taxane Resistance.
Maloney SM; Hoover CA; Morejon-Lasso LV; Prosperi JR
Cancers (Basel); 2020 Nov; 12(11):. PubMed ID: 33182737
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic Inducers of Apoptosis in Ovarian Cancer.
Binju M; Amaya-Padilla MA; Wan G; Gunosewoyo H; Suryo Rahmanto Y; Yu Y
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31766284
[TBL] [Abstract][Full Text] [Related]
39. PI3K inhibitor D-116883 is effective in in vitro models of ovarian cancer.
Honig A; Hahne JC; Meyer S; Kranke P; Häusler S; Diessner J; Dietl J; Engel JB
Anticancer Res; 2012 May; 32(5):2035-41. PubMed ID: 22593485
[TBL] [Abstract][Full Text] [Related]
40. Peptidomimetic GnRH antagonist AEZS-115 inhibits the growth of ovarian and endometrial cancer cells.
Engel JB; Hahne JC; Häusler SF; Meyer S; Segerer SE; Diessner J; Dietl J; Honig A
Anticancer Res; 2012 May; 32(5):2063-8. PubMed ID: 22593489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
